Is ADC Therapeutics S.A. (ADCT) a Buy, Sell, or Hold?
NYSE : ADCT
ADC Therapeutics S.A.
$1.35 USD
$0 (0.0%)
- Volume
- 1.33M
- Average Volume
- 1.89M
- Market Capitalization
- $171.71M
- P/E Ratio
- -1.28
- Dividend Yield
- 0.00%
- Price Target
- $3.50
- Year High
- $4.98
- Year Low
- $0.78
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.09
Analyst Consensus Summary
Consensus Rating
Sell
12 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-61.4%
vs Current Price
Price Target
$3.50
Average TargetPrice Target Range
Lowest Target
$2.00
-32.5% DOWNSIDE
Average Target
$3.50
Median Estimate
Highest Target
$5.00
-73.0% DOWNSIDEAnalyst Breakdown
Overall Consensus: Hold | Total Analysts: 12
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 5 | 6 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Stephens | Sudan Loganathan | $5 | $1.455 | 2026-06-04 09:22 AM | 243.6% |
| RBC Capital | Gregory Renza | $5 | $3.955 | 2025-12-03 01:43 PM | 26.4% |
| Guggenheim | Michael Schmidt | $10 | $3.97 | 2025-11-12 06:47 AM | 151.9% |
| H.C. Wainwright | Robert Burns | $8 | $4.45 | 2024-05-07 03:10 AM | 79.8% |
| Jefferies | Kelly Shi | $13 | $3.9 | 2024-03-13 12:02 PM | 233.3% |
| Morgan Stanley | Matthew Harrison | $11 | $6.52 | 2022-09-09 01:19 AM | 68.7% |